Racial and ethnic disparities in inferior vena cava filter placement for deep vein thrombosis in the United States

• Published in: Journal of vascular surgery. Venous and lymphatic disorders (New York, NY) NY), 2024-01, Vol.12 (1), p.101683, Article 101683
• Main Authors: Juarez, Jordan J., Khalid, Muhammad U., Ulloa, Bianca A., Romero, Carlos M., Maruthi, Rohit, Shah, Devrat, Chang, Eric, Shafi, Irfan, Lakhter, Vladimir, Zhao, Huaqing, Rodriquez, Erik J., Pérez-Stable, Eliseo J., Bashir, Riyaz
• Format: Article
• Language: English
• Subjects: Clinical Research Study; Deep vein thrombosis; Health equity; Inferior vena cava filter; Minority health; Venous thromboembolism
• ISSN: 2213-333X; 2213-3348; 2213-3348
• DOI: 10.1016/j.jvsv.2023.08.022

We sought to determine whether racial and ethnic disparities existed in inferior vena cava (IVC) filter (IVCF) placement rates among Black and Latino patients for the treatment of acute proximal lower extremity (LE) deep vein thrombosis (DVT) in the United States from 2016 to 2019. We performed a retrospective review of National Inpatient Sample data to identify adult patients with a primary discharge diagnosis of acute proximal LE DVT from January 2016 to December 2019, including self-reported patient race and ethnicity. IVCF placement rates were identified using International Classification of Diseases, 10th revision, codes. Weighted multivariable logistic regression was used to compare IVCF use by race and ethnicity. The regression model was adjusted for patient demographics (ie, sex, primary payer, quartile classification of household income), hospital information (ie, region, location, teaching status, bed size), weekend admission, and clinical characteristics (ie, modified Charlson comorbidity index, hypertension, atrial fibrillation, diabetes mellitus type 2, congestive heart failure, dyslipidemia, coronary artery disease, smoking, obesity, alcohol abuse, chronic kidney disease, pulmonary embolism, malignancy, contraindications to anticoagulation, including other major bleeding). Of 134,499 acute proximal LE DVT patients, 18,909 (14.1%) received an IVCF. Of the patients who received an IVCF, 12,733 were White (67.3%), 3563 were Black (18.8%), and 1679 were Latino (8.9%). IVCF placement decreased for all patient groups between 2016 and 2019. After adjusting for the U.S. population distribution, the IVCF placement rates were 11 to 12/100,000 persons for Black patients, 7 to 8/100,000 persons for White patients, and 4 to 5/100,000 persons for Latino patients. The difference in IVCF placement rates was statistically significant between patient groups (Black patients vs White patients, P < .05; Black patients vs Latino patients, P < .05; Latino patients vs White patients, P < .05). This nationwide study showed that Black patients have higher IVCF placement rates compared with White and Latino patients. Given the known long-term complications and uncertain benefits of IVCFs, coupled with the 2010 U.S. Food and Drug Administration safety warning regarding adverse patient events for these devices, proactive measures should be taken to address this disparity among the Black patient population to promote health equity. Future work should assess whether clinic